4.6 Article

FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease

Frank J. Gonzalez et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome

Prue M. Pereira-Fantini et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Pharmacology & Pharmacy

Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease

April D. Lake et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)

Article Medicine, Research & Experimental

Smooth muscle adaptation and recovery of contractility after massive small bowel resection in rats

Jie Chen et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2012)

Article Gastroenterology & Hepatology

Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis

Salvatore Modica et al.

GASTROENTEROLOGY (2012)

Article Endocrinology & Metabolism

Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse

Klementina Fon Tacer et al.

MOLECULAR ENDOCRINOLOGY (2010)